Olga Brawman-Mintzer to Adult
This is a "connection" page, showing publications Olga Brawman-Mintzer has written about Adult.
Connection Strength
0.334
-
Rivastigmine Transdermal Patch Treatment for Moderate to Severe Cognitive Impairment in Veterans with Traumatic Brain Injury (RiVET Study): A Randomized Clinical Trial. J Neurotrauma. 2021 07 15; 38(14):1943-1952.
Score: 0.052
-
Psychosocial characteristics and pain burden of patients with suspected sphincter of Oddi dysfunction in the EPISOD multicenter trial. Am J Gastroenterol. 2014 Mar; 109(3):436-42.
Score: 0.032
-
Attentional functioning in patients with posttraumatic stress disorder: a preliminary study. CNS Spectr. 2013 Apr; 18(2):90-4.
Score: 0.029
-
The role of pain, functioning, and mental health in suicidality among Veterans Affairs primary care patients. Am J Public Health. 2012 Mar; 102 Suppl 1:S118-24.
Score: 0.028
-
Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2006 Jun; 67(6):874-81.
Score: 0.019
-
Patients with generalized anxiety disorder and a history of trauma: somatic symptom endorsement. J Psychiatr Pract. 2005 May; 11(3):212-5.
Score: 0.017
-
The pharmacologic treatment of depression: is gender a critical factor? J Clin Psychiatry. 2002 Jul; 63(7):610-5.
Score: 0.014
-
A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343.
Score: 0.011
-
Panic disorder across the life span: a differential diagnostic approach to treatment resistance. Bull Menninger Clin. 1997; 61(2 Suppl A):A66-94.
Score: 0.010
-
Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies. J Affect Disord. 2016 Dec; 206:151-160.
Score: 0.009
-
Duloxetine for the Treatment of Patients with Suspected Sphincter of Oddi Dysfunction: A Pilot Study. Dig Dis Sci. 2016 09; 61(9):2704-9.
Score: 0.009
-
Generalized anxiety disorder: issues in epidemiology. J Clin Psychiatry. 1996; 57 Suppl 7:3-8.
Score: 0.009
-
Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry. 1995 Nov; 152(11):1665-7.
Score: 0.009
-
Somatic symptoms in generalized anxiety disorder with and without comorbid psychiatric disorders. Am J Psychiatry. 1994 Jun; 151(6):930-2.
Score: 0.008
-
Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISOD randomized clinical trial. JAMA. 2014 May; 311(20):2101-9.
Score: 0.008
-
Can patient and pain characteristics predict manometric sphincter of Oddi dysfunction in patients with clinically suspected sphincter of Oddi dysfunction? Gastrointest Endosc. 2014 May; 79(5):765-72.
Score: 0.008
-
Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug; 150(8):1216-8.
Score: 0.008
-
Extended release quetiapine fumarate (quetiapine XR) monotherapy as maintenance treatment for generalized anxiety disorder: a long-term, randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2011 Jan; 26(1):11-24.
Score: 0.006
-
Challenges in planning and initiating a randomized clinical study of sphincter of Oddi dysfunction. Gastrointest Endosc. 2010 Nov; 72(5):986-91.
Score: 0.006
-
Levetiracetam in generalized social anxiety disorder: a double-blind, randomized controlled trial. J Clin Psychiatry. 2010 May; 71(5):627-31.
Score: 0.006
-
Distribution of complement in the sclera. Invest Ophthalmol Vis Sci. 1989 Oct; 30(10):2240-4.
Score: 0.006
-
The complement system in sclera. Invest Ophthalmol Vis Sci. 1988 Nov; 29(11):1756-8.
Score: 0.006
-
Generalized anxiety disorder in women. Psychiatr Clin North Am. 2001 Mar; 24(1):165-78.
Score: 0.003
-
Bupropion-SR in treatment of social phobia. Depress Anxiety. 2000; 12(2):111-3.
Score: 0.003
-
Evaluation of the efficacy, safety and physiological effects of fluvoxamine in social phobia. Int Clin Psychopharmacol. 1999 Nov; 14(6):345-51.
Score: 0.003
-
Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. J Clin Psychiatry. 1999 May; 60(5):299-301.
Score: 0.003
-
Feasibility of using fMRI to study mothers responding to infant cries. Depress Anxiety. 1999; 10(3):99-104.
Score: 0.003
-
Sleep Deprivation in social phobia and generalized anxiety disorder. Biol Psychiatry. 1998 Jun 01; 43(11):840-2.
Score: 0.003
-
Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry. 1998 Feb 15; 43(4):306-9.
Score: 0.003
-
Sleep deprivation in panic disorder and obsessive-compulsive disorder. Can J Psychiatry. 1997 Nov; 42(9):982-3.
Score: 0.003
-
Phenomenology and course of psychiatric disorders associated with combat-related posttraumatic stress disorder. Am J Psychiatry. 1992 Nov; 149(11):1568-74.
Score: 0.002